Ticker Details
Natera, Inc. Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
IPO Date:	July 2, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$28.77B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.35 | 2.42%
Avg Daily Range (30 D):	$4.76 | 2.40%
Avg Daily Range (90 D):	$3.76 | 1.75%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	1.07M
Avg Daily Volume (90 D):	.95M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	42

Institutional Trades
Total Institutional Trades:	7,378
Avg Institutional Trade:	$5.54M
Avg Institutional Trade (30 D):	$12.12M
Avg Institutional Trade (90 D):	$15M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$11.62M
Avg Closing Trade (30 D):	$43.03M
Avg Closing Trade (90 D):	$38.21M
Avg Closing Volume:	128.83K

News

Mar 31, 2026 @ 4:48 PM Natera's Signatera Data Suggests Select Breast Can... Source: Vandana Singh

Feb 28, 2026 @ 9:37 AM 3 Reasons Exelixis Stock Could Deliver Marketâ€... Source: James Halley

Feb 22, 2026 @ 12:30 AM Billionaire Stanley Druckenmiller Is Betting Big o... Source: Lee Samaha

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Jan 9, 2026 @ 3:53 PM Non-Invasive Prenatal Testing Market is expected t... Source: Verified Market Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.52	$.36	$-1.52
Diluted EPS	$-1.52	$.36	$-1.52
Revenue	$2.31B	$665.5M	$2.31B
Gross Profit
Net Income / Loss	$-208.16M	$47.26M	$-208.16M
Operating Income / Loss	$-309.91M	$-22.79M	$-309.91M
Cost of Revenue
Net Cash Flow	$130.55M	$34.7M	$130.55M
PE Ratio